Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ulab Systems develops a breakthrough software technology for digital dental treatment planning.
Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.
Range Biotechnologies is creating tools to enable personalized health through translational proteomics.
Alveo is a pre-clinical stage medical diagnostics company .
Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.
Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.
10x Science offers an AI software that analyzes protein data to characterize molecular structures and support biopharmaceutical research.
Tacit Therapeutics created RNA-targeting treatments for devastating diseases.
Klivo offers treatments for chronic diseases.
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.
Smart building solutions that automates building and workforce efficiencies, to maximize the ROI of your real estate portfolio.
Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.
Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.
Deep Learning x Synthetic Biology for Novel Protein Therapeutics
Integrated Biosciences develops next-generation therapeutics.
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
Sensible Biotechnologies is developing world's first cell-based platform to unlock the next generation of mRNA medicines.
Wyndly offers personalized prescription treatment and online care.
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
Civilization Ventures has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Civilization Ventures's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 32 different industry categories.
Among tracked funding rounds, R-Zero received $105.0M in a Series C round. Civilization Ventures's total known invested capital is $904.3M.
Civilization Ventures's average investment size is $22.6M across its portfolio of 51 companies.
Recent Civilization Ventures portfolio additions include Ulab Systems, Siren Biotechnology, Range Biotechnologies, Alveo Technologies, Catena Biosciences. These companies were founded in 2020 or later.